CN Patent

CN119836295A — 用于治疗医学病症的肽

Assigned to Humanwell Pharmaceutical US Inc · Expires 2025-04-15 · 1y expired

What this patent protects

本发明提供了作为选择性κ‑阿片受体激动剂的化合物、这些化合物的制备方法、包含这些化合物的组合物以及用于治疗κ‑阿片受体激动剂相关医学病症的方法。

USPTO Abstract

本发明提供了作为选择性κ‑阿片受体激动剂的化合物、这些化合物的制备方法、包含这些化合物的组合物以及用于治疗κ‑阿片受体激动剂相关医学病症的方法。

Drugs covered by this patent

difelikefalin-acetate (DIFELIKEFALIN ACETATE)

Patent Metadata

Patent number: CN119836295A
Jurisdiction: CN
Classification: —
Expires: 2025-04-15
Drug substance claim: No
Drug product claim: No
Assignee: Humanwell Pharmaceutical US Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.